Investigating temporal fluctuations in tumor vasculature with combined carbogen and ultrasmall superparamagnetic iron oxide particle (CUSPIO) imaging

Magnetic Resonance in Medicine

Volumn 66, Issue 1, 2011, Pages 227-234

  Burrell, Jake S ^a   Walker Samuel, Simon ^a,b   Baker, Lauren C J ^a   Boult, Jessica K R ^a   Ryan, Anderson J ^c,d   Waterton, John C ^c   Halliday, Jane ^c   Robinson, Simon P ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ASTRAZENECA   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

hypoxia; tumor; USPIO; vasculature

Indexed keywords

IMAGE SEGMENTATION; MAGNETIC RESONANCE IMAGING; SUPERPARAMAGNETISM; TUMORS;

HISTOLOGICAL ANALYSIS; HYPOXIA; INTRAVENOUS ADMINISTRATION; SEGMENTATION METHODS; TEMPORAL FLUCTUATION; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; USPIO; VASCULATURE;

IRON OXIDES;

BIOLOGICAL MARKER; CARBOGEN; CD31 ANTIGEN; HOE 33342; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAYES THEOREM; BREATHING; COLORECTAL CANCER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; SUSCEPTIBILITY WEIGHTED IMAGING; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

EID: 79959535795     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22779     Document Type: Article

References (30)

1. Denekamp J,. Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br J Radiol 1993; 66: 181-196. (Pubitemid 23096969)
2. Dewhirst MW,. Concepts of oxygen transport at the microcirculatory level. Semin Radiat Oncol 1998; 8: 143-150. (Pubitemid 28323473)
3. Vaupel P, Kallinowski F, Okunieff P,. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989; 49: 6449-6465. (Pubitemid 20008770)
4. Tatum JL, Kelloff GJ, Gillies RJ, Arbeit JM, Brown JM, Chao KS, Chapman JD, Eckelman WC, Fyles AW, Giaccia AJ, Hill RP, Koch CJ, Krishna MC, Krohn KA, Lewis JS, Mason RP, Melillo G, Padhani AR, Powis G, Rajendran JG, Reba R, Robinson SP, Semenza GL, Swartz HM, Vaupel P, Yang D, Croft B, Hoffman J, Liu G, Stone H, Sullivan D,. Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol 2006; 82: 699-757. (Pubitemid 44832019)
5. Heldin CH, Rubin K, Pietras K, Ostman A,. High interstitial fluid pressure-an obstacle in cancer therapy. Nat Rev Cancer 2004; 4: 806-813. (Pubitemid 39331152)
6. Trotter MJ, Chaplin DJ, Durand RE, Olive PL,. The use of fluorescent probes to identify regions of transient perfusion in murine tumors. Int J Radiat Oncol Biol Phys 1989; 16: 931-934. (Pubitemid 19154275)
7. Karczmar GS, River JN, Li J, Vijayakumar S, Goldman Z, Lewis MZ,. Effects of hyperoxia on T2* and resonance frequency weighted magnetic resonance images of rodent tumours. NMR Biomed 1994; 7: 3-11. (Pubitemid 2085018)
8. Robinson SP, Howe FA, Griffiths JR,. Noninvasive monitoring of carbogen-induced changes in tumor blood flow and oxygenation by functional magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1995; 33: 855-859.
9. Corot C, Robert P, Idee JM, Port M,. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 2006; 58: 1471-1504. (Pubitemid 44820503)
10. Gambarota G, van Laarhoven HW, Philippens M, Lok J, van der Kogel A, Punt CJ, Heerschap A,. Assessment of absolute blood volume in carcinoma by USPIO contrast-enhanced MRI. Magn Reson Imaging 2006; 24: 279-286.
11. Jung CW, Jacobs P,. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 1995; 13: 661-674.
12. Tropres I, Grimault S, Vaeth A, Grillon E, Julien C, Payen JF, Lamalle L, Decorps M,. Vessel size imaging. Magn Reson Med 2001; 45: 397-408. (Pubitemid 32173265)
13. Diao Y, Ma J, Xiao WD, Luo J, Li XY, Chu KW, Fung PW, Habib N, Farzaneh F, Xu RA,. Inhibition of angiogenesis and HCT-116 xenograft tumor growth in mice by kallistatin. World J Gastroenterol 2007; 13: 4615-4619. (Pubitemid 47455244)
14. Keyes KA, Mann L, Sherman M, Galbreath E, Schirtzinger L, Ballard D, Chen YF, Iversen P, Teicher BA,. LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing mice. Cancer Chemother Pharmacol 2004; 53: 133-140. (Pubitemid 38186992)
15. Popkov M, Jendreyko N, McGavern DB, Rader C, Barbas CF III,. Targeting tumor angiogenesis with adenovirus-delivered anti-Tie-2 intrabody. Cancer Res 2005; 65: 972-981. (Pubitemid 40216459)
16. Huxham LA, Kyle AH, Baker JH, McNicol KL, Minchinton AI,. Tirapazamine causes vascular dysfunction in HCT-116 tumour xenografts. Radiother Oncol 2006; 78: 138-145. (Pubitemid 43344172)
17. Pedley RB, Hill SA, Boxer GM, Flynn AA, Boden R, Watson R, Dearling J, Chaplin DJ, Begent RH,. Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphate. Cancer Res 2001; 61: 4716-4722. (Pubitemid 32691881)
18. El Emir E, Qureshi U, Dearling JL, Boxer GM, Clatworthy I, Folarin AA, Robson MP, Nagl S, Konerding MA, Pedley RB,. Predicting response to radioimmunotherapy from the tumor microenvironment of colorectal carcinomas. Cancer Res 2007; 67: 11896-11905.
19. Walker-Samuel S, Orton M, McPhail LD, Boult JK, Box G, Eccles SA, Robinson SP,. Bayesian estimation of changes in transverse relaxation rates. Magn Reson Med 2010; 64: 914-921.
20. Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, Double JA, Everitt J, Farningham DA, Glennie MJ, Kelland LR, Robinson V, Stratford IJ, Tozer GM, Watson S, Wedge SR, Eccles SA,. Guidelines for the welfare and use of animals in cancer research. Br J Cancer 2010; 102: 1555-1577.
21. Landuyt W, Sunaert S, Farina D, Meijerink M, Beatse E, Van Hecke P, Hermans R, Marchal G, Lambin P, Bosmans H,. In vivo animal functional MRI: improved image quality with a body-adapted mold. J Magn Reson Imaging 2002; 16: 224-227. (Pubitemid 34810062)
22. Yablonskiy DA, Haacke EM,. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med 1994; 32: 749-763. (Pubitemid 24371176)
23. Smith KA, Hill SA, Begg AC, Denekamp J,. Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours. Br J Cancer 1988; 57: 247-253. (Pubitemid 18096329)
24. Robinson SP, Rijken PF, Howe FA, McSheehy PM, van der Sanden BP, Heerschap A, Stubbs M, van der Kogel AJ, Griffiths JR,. Tumor vascular architecture and function evaluated by non-invasive susceptibility MRI methods and immunohistochemistry. J Magn Reson Imaging 2003; 17: 445-454. (Pubitemid 36396947)
25. Robinson SP, Rodrigues LM, Ojugo AS, McSheehy PM, Howe FA, Griffiths JR,. The response to carbogen breathing in experimental tumour models monitored by gradient-recalled echo magnetic resonance imaging. Br J Cancer 1997; 75: 1000-1006. (Pubitemid 27122618)
26. van Laarhoven HW, Gambarota G, Lok J, Lammens M, Kamm YL, Wagener T, Punt CJ, van der Kogel AJ, Heerschap A,. Carbogen breathing differentially enhances blood plasma volume and 5-fluorouracil uptake in two murine colon tumor models with a distinct vascular structure. Neoplasia 2006; 8: 477-487. (Pubitemid 44035332)
27. Baudelet C, Ansiaux R, Jordan BF, Havaux X, Macq B, Gallez B,. Physiological noise in murine solid tumours using T2*-weighted gradient-echo imaging: a marker of tumour acute hypoxia? Phys Med Biol 2004; 49: 3389-3411. (Pubitemid 39161951)
28. Thomas CD, Chenu E, Walczak C, Plessis MJ, Perin F, Volk A,. Morphological and carbogen-based functional MRI of a chemically induced liver tumor model in mice. Magn Reson Med 2003; 50: 522-530. (Pubitemid 37082077)
29. Baudelet C, Cron GO, Ansiaux R, Crokart N, DeWever J, Feron O, Gallez B,. The role of vessel maturation and vessel functionality in spontaneous fluctuations of T2*-weighted GRE signal within tumors. NMR Biomed 2006; 19: 69-76. (Pubitemid 43250791)
30. Dewhirst MW, Cao Y, Moeller B,. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer 2008; 8: 425-437. (Pubitemid 351744964)